A potential regulatory loop between Lin28B:miR-212 in androgen-independent prostate cancer
Lin28 is a family of RNA binding proteins and microRNA regulators. Two members of this family have been identified: Lin28A and Lin28B, which are encoded by genes localized in different chromosomes but share a high degree of sequence identity. The role of Lin28B in androgen-independent prostate cance...
Uloženo v:
| Vydáno v: | International journal of oncology Ročník 45; číslo 6; s. 2421 - 2429 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Greece
D.A. Spandidos
01.12.2014
Spandidos Publications Spandidos Publications UK Ltd |
| Témata: | |
| ISSN: | 1019-6439, 1791-2423, 1791-2423 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Lin28 is a family of RNA binding proteins and microRNA regulators. Two members of this family have been identified: Lin28A and Lin28B, which are encoded by genes localized in different chromosomes but share a high degree of sequence identity. The role of Lin28B in androgen-independent prostate cancer (AIPC) is not well understood. Lin28B is expressed in all grades of prostatic carcinomas and prostate cancer cell lines, but not in normal prostate tissue. In this study we found that Lin28B co-localized in the nucleus and cytoplasm of the DU145 AIPC. The expression of Lin28B protein positively correlated with the expression of the c-Myc protein in the prostate cancer cell lines and silencing of Lin28B also correlated with a lower expression of the c-Myc protein, but not with the downregulation of c-Myc messenger RNA (mRNA) in the DU145 AIPC cells. We hypothesized that Lin28B regulates the expression of c-Myc protein by altering intermediate c-Myc suppressors. Therefore, a microRNA profile of DU145 cells was performed after Lin28B siRNA silencing. Nineteen microRNAs were upregulated and eleven microRNAs were downregulated. The most upregulated microRNAs were miR-212 and miR-2278. Prior reports have found that miR-212 is suppressed in prostate cancer. We then ran TargetScan software to find potential target mRNAs of miR-212 and miR-2278, and it predicted Lin28B mRNA as a potential target of miR-212, but not miR-2278. TargetScan also predicted that c-Myc mRNA is not a potential target of miR-212 or miR-2278. These observations suggest that Lin28B:miR-212 may work as a regulatory loop in androgen-independent prostate cancer. Furthermore, we report a predictive 2-fold symmetric model generated by the superposition of the Lin28A structure onto the I-TASSER model of Lin28B. This structural model of Lin28B suggests that it shows unique microRNA binding characteristics. Thus, if Lin28B were to bind miRNAs in a manner similar to Lin28A, conformational changes would be necessary to prevent steric clashes in the C-terminal and linker regions between the CSD and ZNF domains. |
|---|---|
| AbstractList | Lin28 is a family of RNA binding proteins and microRNA regulators. Two members of this family have been identified: Lin28A and Lin28B, which are encoded by genes localized in different chromosomes but share a high degree of sequence identity. The role of Lin28B in androgen-independent prostate cancer (AIPC) is not well understood. Lin28B is expressed in all grades of prostatic carcinomas and prostate cancer cell lines, but not in normal prostate tissue. In this study we found that Lin28B co-localized in the nucleus and cytoplasm of the DU145 AIPC. The expression of Lin28B protein positively correlated with the expression of the c-Myc protein in the prostate cancer cell lines and silencing of Lin28B also correlated with a lower expression of the c-Myc protein, but not with the downregulation of c-Myc messenger RNA (mRNA) in the DU145 AIPC cells. We hypothesized that Lin28B regul-ates the expression of c-Myc protein by altering intermediate c-Myc suppressors. Therefore, a microRNA profile of DU145 cells was performed after Lin28B siRNA silencing. Nineteen microRNAs were upregulated and eleven microRNAs were downregulated. The most upregulated microRNAs were miR-212 and miR-2278. Prior reports have found that miR-212 is suppressed in prostate cancer. We then ran TargetScan software to find potential target mRNAs of miR-212 and miR-2278, and it predicted Lin28B mRNA as a potential target of miR-212, but not miR-2278. TargetScan also predicted that c-Myc mRNA is not a potential target of miR-212 or miR-2278. These observations suggest that Lin28B:miR-212 may work as a regulatory loop in androgen-independent prostate cancer. Furthermore, we report a predictive 2-fold symmetric model generated by the superposition of the Lin28A structure onto the I-TASSER model of Lin28B. This structural model of Lin28B suggests that it shows unique microRNA binding characteristics. Thus, if Lin28B were to bind miRNAs in a manner similar to Lin28A, conformational changes would be necessary to prevent steric clashes in the C-terminal and linker regions between the CSD and ZNF domains. Lin28 is a family of RNA binding proteins and microRNA regulators. Two members of this family have been identified: Lin28A and Lin28B, which are encoded by genes localized in different chromosomes but share a high degree of sequence identity. The role of Lin28B in androgen-independent prostate cancer (AIPC) is not well understood. Lin28B is expressed in all grades of prostatic carcinomas and prostate cancer cell lines, but not in normal prostate tissue. In this study we found that Lin28B co-localized in the nucleus and cytoplasm of the DU145 AIPC. The expression of Lin28B protein positively correlated with the expression of the c-Myc protein in the prostate cancer cell lines and silencing of Lin28B also correlated with a lower expression of the c-Myc protein, but not with the downregulation of c-Myc messenger RNA (mRNA) in the DU145 AIPC cells. We hypothesized that Lin28B regulates the expression of c-Myc protein by altering intermediate c-Myc suppressors. Therefore, a microRNA profile of DU145 cells was performed after Lin28B siRNA silencing. Nineteen microRNAs were upregulated and eleven microRNAs were downregulated. The most upregulated microRNAs were miR-212 and miR-2278. Prior reports have found that miR-212 is suppressed in prostate cancer. We then ran TargetScan software to find potential target mRNAs of miR-212 and miR-2278, and it predicted Lin28B mRNA as a potential target of miR-212, but not miR-2278. TargetScan also predicted that c-Myc mRNA is not a potential target of miR-212 or miR-2278. These observations suggest that Lin28B:miR-212 may work as a regulatory loop in androgen-independent prostate cancer. Furthermore, we report a predictive 2-fold symmetric model generated by the superposition of the Lin28A structure onto the I-TASSER model of Lin28B. This structural model of Lin28B suggests that it shows unique microRNA binding characteristics. Thus, if Lin28B were to bind miRNAs in a manner similar to Lin28A, conformational changes would be necessary to prevent steric clashes in the C-terminal and linker regions between the CSD and ZNF domains. Lin28 is a family of RNA binding proteins and microRNA regulators. Two members of this family have been identified: Lin28A and Lin28B, which are encoded by genes localized in different chromosomes but share a high degree of sequence identity. The role of Lin28B in androgen-independent prostate cancer (AIPC) is not well understood. Lin28B is expressed in all grades of prostatic carcinomas and prostate cancer cell lines, but not in normal prostate tissue. In this study we found that Lin28B co-localized in the nucleus and cytoplasm of the DU145 AIPC. The expression of Lin28B protein positively correlated with the expression of the c-Myc protein in the prostate cancer cell lines and silencing of Lin28B also correlated with a lower expression of the c-Myc protein, but not with the downregulation of c-Myc messenger RNA (mRNA) in the DU145 AIPC cells. We hypothesized that Lin28B regulates the expression of c-Myc protein by altering intermediate c-Myc suppressors. Therefore, a microRNA profile of DU145 cells was performed after Lin28B siRNA silencing. Nineteen microRNAs were upregulated and eleven microRNAs were downregulated. The most upregulated microRNAs were miR-212 and miR-2278. Prior reports have found that miR-212 is suppressed in prostate cancer. We then ran TargetScan software to find potential target mRNAs of miR-212 and miR-2278, and it predicted Lin28B mRNA as a potential target of miR-212, but not miR-2278. TargetScan also predicted that c-Myc mRNA is not a potential target of miR-212 or miR-2278. These observations suggest that Lin28B:miR-212 may work as a regulatory loop in androgen-independent prostate cancer. Furthermore, we report a predictive 2-fold symmetric model generated by the superposition of the Lin28A structure onto the I-TASSER model of Lin28B. This structural model of Lin28B suggests that it shows unique microRNA binding characteristics. Thus, if Lin28B were to bind miRNAs in a manner similar to Lin28A, conformational changes would be necessary to prevent steric clashes in the C-terminal and linker regions between the CSD and ZNF domains. Key words: Lin28B-miR-212-c-Myc pathway, miR-212, Lin28B silencing, androgen-independent prostate cancer, microRNA regulation, c-Myc downregulation Lin28 is a family of RNA binding proteins and microRNA regulators. Two members of this family have been identified: Lin28A and Lin28B, which are encoded by genes localized in different chromosomes but share a high degree of sequence identity. The role of Lin28B in androgen-independent prostate cancer (AIPC) is not well understood. Lin28B is expressed in all grades of prostatic carcinomas and prostate cancer cell lines, but not in normal prostate tissue. In this study we found that Lin28B co-localized in the nucleus and cytoplasm of the DU145 AIPC. The expression of Lin28B protein positively correlated with the expression of the c-Myc protein in the prostate cancer cell lines and silencing of Lin28B also correlated with a lower expression of the c-Myc protein, but not with the downregulation of c-Myc messenger RNA (mRNA) in the DU145 AIPC cells. We hypothesized that Lin28B regul-ates the expression of c-Myc protein by altering intermediate c-Myc suppressors. Therefore, a microRNA profile of DU145 cells was performed after Lin28B siRNA silencing. Nineteen microRNAs were upregulated and eleven microRNAs were downregulated. The most upregulated microRNAs were miR-212 and miR-2278. Prior reports have found that miR-212 is suppressed in prostate cancer. We then ran TargetScan software to find potential target mRNAs of miR-212 and miR-2278, and it predicted Lin28B mRNA as a potential target of miR-212, but not miR-2278. TargetScan also predicted that c-Myc mRNA is not a potential target of miR-212 or miR-2278. These observations suggest that Lin28B:miR-212 may work as a regulatory loop in androgen-independent prostate cancer. Furthermore, we report a predictive 2-fold symmetric model generated by the superposition of the Lin28A structure onto the I-TASSER model of Lin28B. This structural model of Lin28B suggests that it shows unique microRNA binding characteristics. Thus, if Lin28B were to bind miRNAs in a manner similar to Lin28A, conformational changes would be necessary to prevent steric clashes in the C-terminal and linker regions between the CSD and ZNF domains.Lin28 is a family of RNA binding proteins and microRNA regulators. Two members of this family have been identified: Lin28A and Lin28B, which are encoded by genes localized in different chromosomes but share a high degree of sequence identity. The role of Lin28B in androgen-independent prostate cancer (AIPC) is not well understood. Lin28B is expressed in all grades of prostatic carcinomas and prostate cancer cell lines, but not in normal prostate tissue. In this study we found that Lin28B co-localized in the nucleus and cytoplasm of the DU145 AIPC. The expression of Lin28B protein positively correlated with the expression of the c-Myc protein in the prostate cancer cell lines and silencing of Lin28B also correlated with a lower expression of the c-Myc protein, but not with the downregulation of c-Myc messenger RNA (mRNA) in the DU145 AIPC cells. We hypothesized that Lin28B regul-ates the expression of c-Myc protein by altering intermediate c-Myc suppressors. Therefore, a microRNA profile of DU145 cells was performed after Lin28B siRNA silencing. Nineteen microRNAs were upregulated and eleven microRNAs were downregulated. The most upregulated microRNAs were miR-212 and miR-2278. Prior reports have found that miR-212 is suppressed in prostate cancer. We then ran TargetScan software to find potential target mRNAs of miR-212 and miR-2278, and it predicted Lin28B mRNA as a potential target of miR-212, but not miR-2278. TargetScan also predicted that c-Myc mRNA is not a potential target of miR-212 or miR-2278. These observations suggest that Lin28B:miR-212 may work as a regulatory loop in androgen-independent prostate cancer. Furthermore, we report a predictive 2-fold symmetric model generated by the superposition of the Lin28A structure onto the I-TASSER model of Lin28B. This structural model of Lin28B suggests that it shows unique microRNA binding characteristics. Thus, if Lin28B were to bind miRNAs in a manner similar to Lin28A, conformational changes would be necessary to prevent steric clashes in the C-terminal and linker regions between the CSD and ZNF domains. |
| Audience | Academic |
| Author | AZIZOV, VUGAR VAN VELDHUIZEN, PETER BORREGO-DIAZ, EMMA McGREGOR, DOUGLAS WANG, XINKUN POWERS, BENJAMIN C DIAZ, FRANCISCO J CHAPMAN, BRADLEY LOVELL, SCOTT TAWFIK, OSSAMA REYES, RUBEN |
| AuthorAffiliation | 2 University of Kansas Cancer Center, Kansas City, KS 66160, USA 1 Division of Hematology/Oncology, Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS 66205, USA 6 Department of Biostatistics, University of Kansas Medical Center, Kansas City, KS 66160, USA 7 Genomic Facility, University of Kansas, Main Campus, Lawrence, KS 66047, USA 3 Veterans Administration Medical Center, Kansas City, MO 64128, USA 4 Protein Structure Laboratory, Del Shankel Structural Biology Center, University of Kansas, Main Campus, Lawrence, KS 66047, USA 5 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA |
| AuthorAffiliation_xml | – name: 3 Veterans Administration Medical Center, Kansas City, MO 64128, USA – name: 1 Division of Hematology/Oncology, Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS 66205, USA – name: 5 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA – name: 4 Protein Structure Laboratory, Del Shankel Structural Biology Center, University of Kansas, Main Campus, Lawrence, KS 66047, USA – name: 7 Genomic Facility, University of Kansas, Main Campus, Lawrence, KS 66047, USA – name: 6 Department of Biostatistics, University of Kansas Medical Center, Kansas City, KS 66160, USA – name: 2 University of Kansas Cancer Center, Kansas City, KS 66160, USA |
| Author_xml | – sequence: 1 givenname: EMMA surname: BORREGO-DIAZ fullname: BORREGO-DIAZ, EMMA organization: Division of Hematology/Oncology, Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS 66205, USA – sequence: 2 givenname: BENJAMIN C surname: POWERS fullname: POWERS, BENJAMIN C organization: Division of Hematology/Oncology, Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS 66205, USA – sequence: 3 givenname: VUGAR surname: AZIZOV fullname: AZIZOV, VUGAR organization: Division of Hematology/Oncology, Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS 66205, USA – sequence: 4 givenname: SCOTT surname: LOVELL fullname: LOVELL, SCOTT organization: Protein Structure Laboratory, Del Shankel Structural Biology Center, University of Kansas, Main Campus, Lawrence, KS 66047, USA – sequence: 5 givenname: RUBEN surname: REYES fullname: REYES, RUBEN organization: Division of Hematology/Oncology, Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS 66205, USA – sequence: 6 givenname: BRADLEY surname: CHAPMAN fullname: CHAPMAN, BRADLEY organization: Division of Hematology/Oncology, Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS 66205, USA – sequence: 7 givenname: OSSAMA surname: TAWFIK fullname: TAWFIK, OSSAMA organization: University of Kansas Cancer Center, Kansas City, KS 66160, USA – sequence: 8 givenname: DOUGLAS surname: McGREGOR fullname: McGREGOR, DOUGLAS organization: Veterans Administration Medical Center, Kansas City, MO 64128, USA – sequence: 9 givenname: FRANCISCO J surname: DIAZ fullname: DIAZ, FRANCISCO J organization: University of Kansas Cancer Center, Kansas City, KS 66160, USA – sequence: 10 givenname: XINKUN surname: WANG fullname: WANG, XINKUN organization: Genomic Facility, University of Kansas, Main Campus, Lawrence, KS 66047, USA – sequence: 11 givenname: PETER surname: VAN VELDHUIZEN fullname: VAN VELDHUIZEN, PETER organization: Division of Hematology/Oncology, Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS 66205, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25201220$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1ktuL1DAUxousuBd99FUKgvrSMZemTX0QxsUbDAiiL76ETHI6kyGT1KRV9r_3lNlddxYlkJT09309Pec7L05CDFAUTylZcNmx124XF4zQesGaun1QnNG2oxWrGT_BZ0K7qql5d1qc57wjhAlB6KPilAmUMEbOih_LcogjhNFpXybYTF6PMV2VPsahXMP4GyCUKxeYfPdm775WjLLShVIHm-IGQuWChQFwC2M5pJhHPUJpdDCQHhcPe-0zPLk-L4rvH95_u_xUrb58_Hy5XFVG1GKsLICotW4baYhsgVDZGdkQy0jfg4F-bQ0nvAXZctN3lmrWkLa21BqxFkYCvyjeHnyHab0Ha7CUpL0aktvrdKWidur4TXBbtYm_VM2oEJKhwatrgxR_TpBHtXfZgPc6QJyyog3F3rZcEESf30N3cUoBf0_RjjOJze_kX2qjPSgX-ojfNbOpWtaEckmEpEgt_kHhsrB3BqfcO7w_Ery4I9iC9uM2Rz-NLoZ8DD6725HbVtyMHQF-AAyOLCfolXE4OfTBEpxXlKg5XArDpeZwqTlcqKruqW6M_8e_PPB5wLw4G_OtAMGqFhVp5qhS_gf1JtvT |
| CitedBy_id | crossref_primary_10_2217_fon_2021_0247 crossref_primary_10_1002_pros_23241 crossref_primary_10_3892_or_2017_5805 crossref_primary_10_1016_j_jds_2022_05_018 crossref_primary_10_1111_jcmm_12733 crossref_primary_10_1111_jcmm_14966 crossref_primary_10_1007_s12672_021_00433_6 crossref_primary_10_1080_15257770_2020_1859116 crossref_primary_10_1186_s12943_015_0402_5 crossref_primary_10_3389_fimmu_2020_574046 crossref_primary_10_1007_s00277_024_06169_x crossref_primary_10_1038_srep42680 crossref_primary_10_3390_cancers14194640 crossref_primary_10_1002_1873_3468_15004 crossref_primary_10_1002_ajhb_22887 crossref_primary_10_1080_15384101_2018_1482137 |
| Cites_doi | 10.1002/jcb.24565 10.1530/ERC-12-0207 10.1002/ijc.24827 10.1016/j.canlet.2011.01.016 10.1182/blood-2013-01-478222 10.3322/caac.20107 10.1007/978-94-007-5590-1_3 10.1016/j.ygyno.2010.09.009 10.1053/j.seminoncol.2011.08.006 10.1371/journal.pone.0032832 10.1006/meth.2001.1262 10.1007/s00441-012-1514-5 10.1093/carcin/bgr272 10.1007/s12032-013-0577-9 10.7150/jca.6394 10.1038/nprot.2010.5 10.1074/jbc.M112.434340 10.1016/j.febslet.2012.09.034 10.7314/APJCP.2013.14.5.3063 10.1371/journal.pone.0012445 10.1038/bjc.2012.525 10.1371/journal.pone.0027722 10.1016/j.urology.2013.10.026 10.1517/17460441.2013.855194 10.1002/pros.22466 10.1016/j.ijrobp.2009.08.028 10.1016/j.ejso.2008.06.006 10.1210/en.2012-1745 10.1261/rna.036491.112 10.1002/pros.22497 10.1016/j.cell.2011.10.020 10.1172/JCI58849 10.1016/j.biocel.2013.02.006 10.1016/j.ajpath.2013.03.011 10.1002/mc.21832 |
| ContentType | Journal Article |
| Copyright | Copyright © 2014, Spandidos Publications COPYRIGHT 2014 Spandidos Publications Copyright Spandidos Publications UK Ltd. 2014 Copyright © 2014, Spandidos Publications 2014 |
| Copyright_xml | – notice: Copyright © 2014, Spandidos Publications – notice: COPYRIGHT 2014 Spandidos Publications – notice: Copyright Spandidos Publications UK Ltd. 2014 – notice: Copyright © 2014, Spandidos Publications 2014 |
| DBID | HUR AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AN0 BENPR CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.3892/ijo.2014.2647 |
| DatabaseName | Spandidos Publications Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central ProQuest Central UK/Ireland British Nursing Database ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE ProQuest One Academic Middle East (New) MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7RV name: Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1791-2423 |
| EndPage | 2429 |
| ExternalDocumentID | PMC4215582 A401380581 25201220 10_3892_ijo_2014_2647 ijo-45-06-2421 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | United States United States--US |
| GeographicLocations_xml | – name: United States – name: United States--US |
| GrantInformation_xml | – fundername: NCATS NIH HHS grantid: UL1TR000001-02 – fundername: NIGMS NIH HHS grantid: 8P20GM103420-10 – fundername: NCRR NIH HHS grantid: 5P20RR017708-10 – fundername: NIGMS NIH HHS grantid: P30 GM103326 – fundername: NIGMS NIH HHS grantid: P20 GM103420 – fundername: NCATS NIH HHS grantid: UL1 TR000001 – fundername: NCRR NIH HHS grantid: P20 RR017708 |
| GroupedDBID | --- 0R~ 2WC 53G 5GY 7RV 7X7 88E 8FI 8FJ AAFWJ ABJNI ABPMR ABUWG ACGFO ACGFS ADBBV AEGXH AENEX AFKRA AHMBA AIAGR ALMA_UNASSIGNED_HOLDINGS AN0 BAWUL BENPR BKEYQ BNQBC BPHCQ BVXVI C45 CCPQU CS3 DIK DU5 E3Z EBD EBS EJD EMOBN F5P FYUFA H13 HMCUK HUR HZ~ IAO IHR IHW INH INR IPNFZ ITC L7B M1P NAPCQ O9- ODZKP OGEVE OK1 OVD P2P PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RIG SV3 TEORI TR2 UDS UKHRP ZXP AAYXX AFFHD CITATION CGR CUY CVF ECM EIF NPM AFOSN ALIPV 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c545t-dee54aa768c087e0189c860d20ffecefbdc3037e873cf9d1a26074d1dc5b5c8e3 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 22 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000344200700027&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1019-6439 1791-2423 |
| IngestDate | Tue Nov 04 01:58:23 EST 2025 Fri Jul 11 00:05:50 EDT 2025 Tue Oct 07 07:11:09 EDT 2025 Tue Nov 11 10:25:13 EST 2025 Tue Nov 04 17:40:06 EST 2025 Thu May 22 21:24:46 EDT 2025 Thu Jan 02 22:14:59 EST 2025 Sat Nov 29 05:22:11 EST 2025 Tue Nov 18 21:05:56 EST 2025 Tue Sep 30 17:19:13 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 6 |
| Language | English |
| License | This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c545t-dee54aa768c087e0189c860d20ffecefbdc3037e873cf9d1a26074d1dc5b5c8e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Contributed equally |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC4215582 |
| PMID | 25201220 |
| PQID | 1932879198 |
| PQPubID | 2044957 |
| PageCount | 9 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4215582 proquest_miscellaneous_1616477350 proquest_journals_1932879198 gale_infotracmisc_A401380581 gale_infotracacademiconefile_A401380581 gale_healthsolutions_A401380581 pubmed_primary_25201220 crossref_citationtrail_10_3892_ijo_2014_2647 crossref_primary_10_3892_ijo_2014_2647 spandidos_primary_ijo-45-06-2421 |
| PublicationCentury | 2000 |
| PublicationDate | 2014-12-01 |
| PublicationDateYYYYMMDD | 2014-12-01 |
| PublicationDate_xml | – month: 12 year: 2014 text: 2014-12-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Greece |
| PublicationPlace_xml | – name: Greece – name: Athens |
| PublicationTitle | International journal of oncology |
| PublicationTitleAlternate | Int J Oncol |
| PublicationYear | 2014 |
| Publisher | D.A. Spandidos Spandidos Publications Spandidos Publications UK Ltd |
| Publisher_xml | – name: D.A. Spandidos – name: Spandidos Publications – name: Spandidos Publications UK Ltd |
| References | Jones, Zabolotskaya, King (b16-ijo-45-06-2421) 2012; 107 Trendel (b3-ijo-45-06-2421) 2013; 8 Nurul-Syakima, Yoke-Kqueen, Sabariah, Shiran, Singh, Learn-Han (b19-ijo-45-06-2421) 2011; 28 Ali, Ghoshdastider, Hoffmann, Brutschy, Filipek (b34-ijo-45-06-2421) 2012; 586 Ferrajoli, Shanafelt, Ivan (b25-ijo-45-06-2421) 2013; 122 Cui, Hou, Lei (b27-ijo-45-06-2421) 2013; 14 Man, Fu, Liu (b31-ijo-45-06-2421) 2011; 8 Gaytan, Sangiao-Alvarellos, Manfredi-Lozano (b9-ijo-45-06-2421) 2013; 154 Kashat, Azzouz, Sarkar, Kong, Li, Sarkar (b29-ijo-45-06-2421) 2012; 4 Schaefer, Jung, Mollenkopf (b30-ijo-45-06-2421) 2010; 126 Kong, Banerjee, Ahmad (b38-ijo-45-06-2421) 2010; 5 Hafner, Max, Bandaru (b7-ijo-45-06-2421) 2013; 19 Tummala, Nadiminty, Lou (b10-ijo-45-06-2421) 2013; 183 Hu, Li, Cui (b22-ijo-45-06-2421) 2013; 288 Oh, Kim, Byun, Kim (b26-ijo-45-06-2421) 2010; 76 Xu, Wang, Wang (b15-ijo-45-06-2421) 2012; 72 Bray, Tivnan, Bryan (b32-ijo-45-06-2421) 2011; 303 Vencio, Nelson, Cavanaugh (b37-ijo-45-06-2421) 2012; 72 Mirnezami, Pickard, Zhang, Primrose, Packham (b4-ijo-45-06-2421) 2009; 35 Nam, Chen, Gregory, Chou, Sliz (b35-ijo-45-06-2421) 2011; 147 Walter, Valera, Pinto, Merino (b13-ijo-45-06-2421) 2013; 4 Sand, Skrygan, Sand (b18-ijo-45-06-2421) 2013; 351 Crawford, Stone, Yu (b2-ijo-45-06-2421) 2014; 83 Xu, Liang, Cui, Wu, Shi, Liu (b21-ijo-45-06-2421) 2013; 52 Nadiminty, Tummala, Lou (b36-ijo-45-06-2421) 2012; 7 Incoronato, Urso, Portela (b14-ijo-45-06-2421) 2011; 6 Zhou, Ng, Chng (b8-ijo-45-06-2421) 2013; 45 Jemal, Bray, Center, Ferlay, Ward, Forman (b1-ijo-45-06-2421) 2011; 61 An, Pan, Yan (b23-ijo-45-06-2421) 2013; 114 Roy, Kucukural, Zhang (b12-ijo-45-06-2421) 2010; 5 Li, Xiao, Zhang (b24-ijo-45-06-2421) 2011; 120 Lovat, Valeri, Croce (b6-ijo-45-06-2421) 2011; 38 Ritchie, Rasko, Flamant (b5-ijo-45-06-2421) 2013; 774 Livak, Schmittgen (b11-ijo-45-06-2421) 2001; 25 Wang, Zhang, Zhang, Li, Shan, Teng (b20-ijo-45-06-2421) 2013; 30 Yang, Li, Cheng (b33-ijo-45-06-2421) 2012; 33 Jiang, Lin, Song (b28-ijo-45-06-2421) 2012; 122 Endo, Toyama, Takahashi (b17-ijo-45-06-2421) 2013; 20 Zhou (key20180107182109_b8-ijo-45-06-2421) 2013; 45 Jones (key20180107182109_b16-ijo-45-06-2421) 2012; 107 Kashat (key20180107182109_b29-ijo-45-06-2421) 2012; 4 Wang (key20180107182109_b20-ijo-45-06-2421) 2013; 30 Ferrajoli (key20180107182109_b25-ijo-45-06-2421) 2013; 122 Trendel (key20180107182109_b3-ijo-45-06-2421) 2013; 8 Walter (key20180107182109_b13-ijo-45-06-2421) 2013; 4 Hu (key20180107182109_b22-ijo-45-06-2421) 2013; 288 Ali (key20180107182109_b34-ijo-45-06-2421) 2012; 586 Mirnezami (key20180107182109_b4-ijo-45-06-2421) 2009; 35 Endo (key20180107182109_b17-ijo-45-06-2421) 2013; 20 Nurul-Syakima (key20180107182109_b19-ijo-45-06-2421) 2011; 28 Crawford (key20180107182109_b2-ijo-45-06-2421) 2014; 83 Man (key20180107182109_b31-ijo-45-06-2421) 2011; 8 Livak (key20180107182109_b11-ijo-45-06-2421) 2001; 25 Nadiminty (key20180107182109_b36-ijo-45-06-2421) 2012; 7 Vencio (key20180107182109_b37-ijo-45-06-2421) 2012; 72 Gaytan (key20180107182109_b9-ijo-45-06-2421) 2013; 154 Kong (key20180107182109_b38-ijo-45-06-2421) 2010; 5 Schaefer (key20180107182109_b30-ijo-45-06-2421) 2010; 126 Sand (key20180107182109_b18-ijo-45-06-2421) 2013; 351 Xu (key20180107182109_b21-ijo-45-06-2421) 2013; 52 Nam (key20180107182109_b35-ijo-45-06-2421) 2011; 147 Jemal (key20180107182109_b1-ijo-45-06-2421) 2011; 61 Roy (key20180107182109_b12-ijo-45-06-2421) 2010; 5 An (key20180107182109_b23-ijo-45-06-2421) 2013; 114 Li (key20180107182109_b24-ijo-45-06-2421) 2011; 120 Bray (key20180107182109_b32-ijo-45-06-2421) 2011; 303 Ritchie (key20180107182109_b5-ijo-45-06-2421) 2013; 774 Lovat (key20180107182109_b6-ijo-45-06-2421) 2011; 38 Cui (key20180107182109_b27-ijo-45-06-2421) 2013; 14 Xu (key20180107182109_b15-ijo-45-06-2421) 2012; 72 Oh (key20180107182109_b26-ijo-45-06-2421) 2010; 76 Jiang (key20180107182109_b28-ijo-45-06-2421) 2012; 122 Hafner (key20180107182109_b7-ijo-45-06-2421) 2013; 19 Tummala (key20180107182109_b10-ijo-45-06-2421) 2013; 183 Incoronato (key20180107182109_b14-ijo-45-06-2421) 2011; 6 Yang (key20180107182109_b33-ijo-45-06-2421) 2012; 33 23553990 - J Cell Biochem. 2013 Sep;114(9):2160-9 23337528 - Endocrinology. 2013 Mar;154(3):1321-36 23420006 - Int J Biochem Cell Biol. 2013 May;45(5):973-8 21310526 - Cancer Lett. 2011 Apr 1;303(1):56-64 20947150 - Gynecol Oncol. 2011 Jan;120(1):145-51 21296855 - CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90 23803080 - Asian Pac J Cancer Prev. 2013;14(5):3063-6 22114071 - Carcinogenesis. 2012 Feb;33(2):338-47 22121083 - Mol Carcinog. 2013 Jan;52(1):70-8 23063642 - FEBS Lett. 2012 Nov 16;586(22):3986-90 20360767 - Nat Protoc. 2010 Apr;5(4):725-38 11846609 - Methods. 2001 Dec;25(4):402-8 23169280 - Br J Cancer. 2012 Dec 4;107(12):1987-96 23436656 - J Biol Chem. 2013 Apr 19;288(16):10973-85 21637912 - Int J Mol Med. 2011 Sep;28(3):327-36 20805998 - PLoS One. 2010;5(8):e12445 20005451 - Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):5-8 23790802 - Am J Pathol. 2013 Jul;183(1):288-95 23481595 - RNA. 2013 May;19(5):613-26 23821659 - Blood. 2013 Sep 12;122(11):1891-9 18644693 - Eur J Surg Oncol. 2009 Apr;35(4):339-47 22156201 - J Clin Invest. 2012 Jan;122(1):33-47 22082758 - Semin Oncol. 2011 Dec;38(6):724-33 23145211 - Am J Transl Res. 2012;4(4):432-42 22078496 - Cell. 2011 Nov 23;147(5):1080-91 21980038 - Cancer Genomics Proteomics. 2011 Sep-Oct;8(5):235-44 23377967 - Adv Exp Med Biol. 2013;774:39-53 24411213 - Urology. 2014 Mar;83(3):664-9 22479342 - PLoS One. 2012;7(3):e32832 19676045 - Int J Cancer. 2010 Mar 1;126(5):1166-76 24206221 - Expert Opin Drug Discov. 2013 Dec;8(12):1491-501 22314551 - Prostate. 2012 Sep 15;72(13):1453-63 22161865 - Prostate. 2012 Aug 1;72(11):1171-8 22110741 - PLoS One. 2011;6(11):e27722 23781281 - J Cancer. 2013 May 09;4(5):350-7 23183268 - Endocr Relat Cancer. 2013 Feb;20(1):91-102 23609190 - Med Oncol. 2013;30(2):577 23111773 - Cell Tissue Res. 2013 Jan;351(1):85-98 |
| References_xml | – volume: 303 start-page: 56 year: 2011 end-page: 64 ident: b32-ijo-45-06-2421 article-title: MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma publication-title: Cancer Lett – volume: 154 start-page: 1321 year: 2013 end-page: 1336 ident: b9-ijo-45-06-2421 article-title: Distinct expression patterns predict differential roles of the miRNA-binding proteins, Lin28 and Lin28b, in the mouse testis: studies during postnatal development and in a model of hypogonadotropic hypogonadism publication-title: Endocrinology – volume: 122 start-page: 33 year: 2012 end-page: 47 ident: b28-ijo-45-06-2421 article-title: MicroRNA-30e promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop publication-title: J Clin Invest – volume: 19 start-page: 613 year: 2013 end-page: 626 ident: b7-ijo-45-06-2421 article-title: Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition publication-title: RNA – volume: 5 start-page: e12445 year: 2010 ident: b38-ijo-45-06-2421 article-title: Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells publication-title: PLoS One – volume: 33 start-page: 338 year: 2012 end-page: 347 ident: b33-ijo-45-06-2421 article-title: A functional polymorphism at microRNA-629-binding site in the 3′-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population publication-title: Carcinogenesis – volume: 38 start-page: 724 year: 2011 end-page: 733 ident: b6-ijo-45-06-2421 article-title: MicroRNAs in the pathogenesis of cancer publication-title: Semin Oncol – volume: 76 start-page: 5 year: 2010 end-page: 8 ident: b26-ijo-45-06-2421 article-title: Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras publication-title: Int J Radiat Oncol Biol Phys – volume: 114 start-page: 2160 year: 2013 end-page: 2169 ident: b23-ijo-45-06-2421 article-title: MiR-23a in amplified 19p13.13 loci targets metallothionein 2A and promotes growth in gastric cancer cells publication-title: J Cell Biochem – volume: 35 start-page: 339 year: 2009 end-page: 347 ident: b4-ijo-45-06-2421 article-title: MicroRNAs: key players in carcinogenesis and novel therapeutic targets publication-title: Eur J Surg Oncol – volume: 4 start-page: 350 year: 2013 end-page: 357 ident: b13-ijo-45-06-2421 article-title: Comprehensive microRNA profiling of prostate cancer publication-title: J Cancer – volume: 586 start-page: 3986 year: 2012 end-page: 3990 ident: b34-ijo-45-06-2421 article-title: Recognition of the let-7g miRNA precursor by human Lin28B publication-title: FEBS Lett – volume: 147 start-page: 1080 year: 2011 end-page: 1091 ident: b35-ijo-45-06-2421 article-title: Molecular basis for interaction of let-7 microRNAs with Lin28 publication-title: Cell – volume: 183 start-page: 288 year: 2013 end-page: 295 ident: b10-ijo-45-06-2421 article-title: Lin28 promotes growth of prostate cancer cells and activates the androgen receptor publication-title: Am J Pathol – volume: 122 start-page: 1891 year: 2013 end-page: 1899 ident: b25-ijo-45-06-2421 article-title: Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia publication-title: Blood – volume: 61 start-page: 69 year: 2011 end-page: 90 ident: b1-ijo-45-06-2421 article-title: Global cancer statistics publication-title: CA Cancer J Clin – volume: 351 start-page: 85 year: 2013 end-page: 98 ident: b18-ijo-45-06-2421 article-title: Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi publication-title: Cell Tissue Res – volume: 25 start-page: 402 year: 2001 end-page: 408 ident: b11-ijo-45-06-2421 article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method publication-title: Methods – volume: 4 start-page: 432 year: 2012 end-page: 442 ident: b29-ijo-45-06-2421 article-title: Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness publication-title: Am J Transl Res – volume: 28 start-page: 327 year: 2011 end-page: 336 ident: b19-ijo-45-06-2421 article-title: Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers publication-title: Int J Mol Med – volume: 120 start-page: 145 year: 2011 end-page: 151 ident: b24-ijo-45-06-2421 article-title: MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells publication-title: Gynecol Oncol – volume: 774 start-page: 39 year: 2013 end-page: 53 ident: b5-ijo-45-06-2421 article-title: MicroRNA target prediction and validation publication-title: Adv Exp Med Biol – volume: 52 start-page: 70 year: 2013 end-page: 78 ident: b21-ijo-45-06-2421 article-title: miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells publication-title: Mol Carcinog – volume: 20 start-page: 91 year: 2013 end-page: 102 ident: b17-ijo-45-06-2421 article-title: miR-1290 and its potential targets are associated with characteristics of estrogen receptor alpha-positive breast cancer publication-title: Endocr Relat Cancer – volume: 7 start-page: e32832 year: 2012 ident: b36-ijo-45-06-2421 article-title: MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth publication-title: PLoS One – volume: 14 start-page: 3063 year: 2013 end-page: 3066 ident: b27-ijo-45-06-2421 article-title: Upregulation of microRNA 181c expression in gastric cancer tissues and plasma publication-title: Asian Pac J Cancer Prev – volume: 5 start-page: 725 year: 2010 end-page: 738 ident: b12-ijo-45-06-2421 article-title: I-TASSER: a unified platform for automated protein structure and function prediction publication-title: Nat Protoc – volume: 45 start-page: 973 year: 2013 end-page: 978 ident: b8-ijo-45-06-2421 article-title: LIN28/LIN28B: an emerging oncogenic driver in cancer stem cells publication-title: Int J Biochem Cell Biol – volume: 126 start-page: 1166 year: 2010 end-page: 1176 ident: b30-ijo-45-06-2421 article-title: Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma publication-title: Int J Cancer – volume: 83 start-page: 664 year: 2014 end-page: 669 ident: b2-ijo-45-06-2421 article-title: Challenges and recommendations for early identification of metastatic disease in prostate cancer publication-title: Urology – volume: 288 start-page: 10973 year: 2013 end-page: 10985 ident: b22-ijo-45-06-2421 article-title: The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2) publication-title: J Biol Chem – volume: 6 start-page: e27722 year: 2011 ident: b14-ijo-45-06-2421 article-title: Epigenetic regulation of miR-212 expression in lung cancer publication-title: PLoS One – volume: 107 start-page: 1987 year: 2012 end-page: 1996 ident: b16-ijo-45-06-2421 article-title: Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma publication-title: Br J Cancer – volume: 8 start-page: 1491 year: 2013 end-page: 1501 ident: b3-ijo-45-06-2421 article-title: The hurdle of antiandrogen drug resistance: drug design strategies publication-title: Expert Opin Drug Discov – volume: 72 start-page: 1453 year: 2012 end-page: 1463 ident: b37-ijo-45-06-2421 article-title: Reprogramming of prostate cancer-associated stromal cells to embryonic stem-like publication-title: Prostate – volume: 8 start-page: 235 year: 2011 end-page: 244 ident: b31-ijo-45-06-2421 article-title: Aberrant expression of chromogranin A, miR-146a, and miR-146b-5p in prostate structures with focally disrupted basal cell layers: an early sign of invasion and hormone-refractory cancer? publication-title: Cancer Genomics Proteomics – volume: 72 start-page: 1171 year: 2012 end-page: 1178 ident: b15-ijo-45-06-2421 article-title: MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer publication-title: Prostate – volume: 30 start-page: 577 year: 2013 ident: b20-ijo-45-06-2421 article-title: Upregulation of miR-2861 and miR-451 expression in papillary thyroid carcinoma with lymph node metastasis publication-title: Med Oncol – volume: 114 start-page: 2160 year: 2013 ident: key20180107182109_b23-ijo-45-06-2421 article-title: MiR-23a in amplified 19p13.13 loci targets metallothionein 2A and promotes growth in gastric cancer cells publication-title: J Cell Biochem doi: 10.1002/jcb.24565 – volume: 20 start-page: 91 year: 2013 ident: key20180107182109_b17-ijo-45-06-2421 article-title: miR-1290 and its potential targets are associated with characteristics of estrogen receptor alpha-positive breast cancer publication-title: Endocr Relat Cancer doi: 10.1530/ERC-12-0207 – volume: 126 start-page: 1166 year: 2010 ident: key20180107182109_b30-ijo-45-06-2421 article-title: Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma publication-title: Int J Cancer doi: 10.1002/ijc.24827 – volume: 8 start-page: 235 year: 2011 ident: key20180107182109_b31-ijo-45-06-2421 article-title: Aberrant expression of chromogranin A, miR-146a, and miR-146b-5p in prostate structures with focally disrupted basal cell layers: an early sign of invasion and hormone-refractory cancer? publication-title: Cancer Genomics Proteomics – volume: 303 start-page: 56 year: 2011 ident: key20180107182109_b32-ijo-45-06-2421 article-title: MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma publication-title: Cancer Lett doi: 10.1016/j.canlet.2011.01.016 – volume: 122 start-page: 1891 year: 2013 ident: key20180107182109_b25-ijo-45-06-2421 article-title: Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood-2013-01-478222 – volume: 61 start-page: 69 year: 2011 ident: key20180107182109_b1-ijo-45-06-2421 article-title: Global cancer statistics publication-title: CA Cancer J Clin doi: 10.3322/caac.20107 – volume: 774 start-page: 39 year: 2013 ident: key20180107182109_b5-ijo-45-06-2421 article-title: MicroRNA target prediction and validation publication-title: Adv Exp Med Biol doi: 10.1007/978-94-007-5590-1_3 – volume: 120 start-page: 145 year: 2011 ident: key20180107182109_b24-ijo-45-06-2421 article-title: MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2010.09.009 – volume: 38 start-page: 724 year: 2011 ident: key20180107182109_b6-ijo-45-06-2421 article-title: MicroRNAs in the pathogenesis of cancer publication-title: Semin Oncol doi: 10.1053/j.seminoncol.2011.08.006 – volume: 7 start-page: e32832 year: 2012 ident: key20180107182109_b36-ijo-45-06-2421 article-title: MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth publication-title: PLoS One doi: 10.1371/journal.pone.0032832 – volume: 25 start-page: 402 year: 2001 ident: key20180107182109_b11-ijo-45-06-2421 article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method publication-title: Methods doi: 10.1006/meth.2001.1262 – volume: 351 start-page: 85 year: 2013 ident: key20180107182109_b18-ijo-45-06-2421 article-title: Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi publication-title: Cell Tissue Res doi: 10.1007/s00441-012-1514-5 – volume: 33 start-page: 338 year: 2012 ident: key20180107182109_b33-ijo-45-06-2421 article-title: A functional polymorphism at microRNA-629-binding site in the 3′-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population publication-title: Carcinogenesis doi: 10.1093/carcin/bgr272 – volume: 30 start-page: 577 year: 2013 ident: key20180107182109_b20-ijo-45-06-2421 article-title: Upregulation of miR-2861 and miR-451 expression in papillary thyroid carcinoma with lymph node metastasis publication-title: Med Oncol doi: 10.1007/s12032-013-0577-9 – volume: 4 start-page: 350 year: 2013 ident: key20180107182109_b13-ijo-45-06-2421 article-title: Comprehensive microRNA profiling of prostate cancer publication-title: J Cancer doi: 10.7150/jca.6394 – volume: 5 start-page: 725 year: 2010 ident: key20180107182109_b12-ijo-45-06-2421 article-title: I-TASSER: a unified platform for automated protein structure and function prediction publication-title: Nat Protoc doi: 10.1038/nprot.2010.5 – volume: 288 start-page: 10973 year: 2013 ident: key20180107182109_b22-ijo-45-06-2421 article-title: The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2) publication-title: J Biol Chem doi: 10.1074/jbc.M112.434340 – volume: 586 start-page: 3986 year: 2012 ident: key20180107182109_b34-ijo-45-06-2421 article-title: Recognition of the let-7g miRNA precursor by human Lin28B publication-title: FEBS Lett doi: 10.1016/j.febslet.2012.09.034 – volume: 14 start-page: 3063 year: 2013 ident: key20180107182109_b27-ijo-45-06-2421 article-title: Upregulation of microRNA 181c expression in gastric cancer tissues and plasma publication-title: Asian Pac J Cancer Prev doi: 10.7314/APJCP.2013.14.5.3063 – volume: 5 start-page: e12445 year: 2010 ident: key20180107182109_b38-ijo-45-06-2421 article-title: Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells publication-title: PLoS One doi: 10.1371/journal.pone.0012445 – volume: 107 start-page: 1987 year: 2012 ident: key20180107182109_b16-ijo-45-06-2421 article-title: Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma publication-title: Br J Cancer doi: 10.1038/bjc.2012.525 – volume: 6 start-page: e27722 year: 2011 ident: key20180107182109_b14-ijo-45-06-2421 article-title: Epigenetic regulation of miR-212 expression in lung cancer publication-title: PLoS One doi: 10.1371/journal.pone.0027722 – volume: 83 start-page: 664 year: 2014 ident: key20180107182109_b2-ijo-45-06-2421 article-title: Challenges and recommendations for early identification of metastatic disease in prostate cancer publication-title: Urology doi: 10.1016/j.urology.2013.10.026 – volume: 8 start-page: 1491 year: 2013 ident: key20180107182109_b3-ijo-45-06-2421 article-title: The hurdle of antiandrogen drug resistance: drug design strategies publication-title: Expert Opin Drug Discov doi: 10.1517/17460441.2013.855194 – volume: 72 start-page: 1171 year: 2012 ident: key20180107182109_b15-ijo-45-06-2421 article-title: MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer publication-title: Prostate doi: 10.1002/pros.22466 – volume: 76 start-page: 5 year: 2010 ident: key20180107182109_b26-ijo-45-06-2421 article-title: Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2009.08.028 – volume: 35 start-page: 339 year: 2009 ident: key20180107182109_b4-ijo-45-06-2421 article-title: MicroRNAs: key players in carcinogenesis and novel therapeutic targets publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2008.06.006 – volume: 4 start-page: 432 year: 2012 ident: key20180107182109_b29-ijo-45-06-2421 article-title: Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness publication-title: Am J Transl Res – volume: 154 start-page: 1321 year: 2013 ident: key20180107182109_b9-ijo-45-06-2421 article-title: Distinct expression patterns predict differential roles of the miRNA-binding proteins, Lin28 and Lin28b, in the mouse testis: studies during postnatal development and in a model of hypogonadotropic hypogonadism publication-title: Endocrinology doi: 10.1210/en.2012-1745 – volume: 19 start-page: 613 year: 2013 ident: key20180107182109_b7-ijo-45-06-2421 article-title: Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition publication-title: RNA doi: 10.1261/rna.036491.112 – volume: 72 start-page: 1453 year: 2012 ident: key20180107182109_b37-ijo-45-06-2421 article-title: Reprogramming of prostate cancer-associated stromal cells to embryonic stem-like publication-title: Prostate doi: 10.1002/pros.22497 – volume: 147 start-page: 1080 year: 2011 ident: key20180107182109_b35-ijo-45-06-2421 article-title: Molecular basis for interaction of let-7 microRNAs with Lin28 publication-title: Cell doi: 10.1016/j.cell.2011.10.020 – volume: 28 start-page: 327 year: 2011 ident: key20180107182109_b19-ijo-45-06-2421 article-title: Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers publication-title: Int J Mol Med – volume: 122 start-page: 33 year: 2012 ident: key20180107182109_b28-ijo-45-06-2421 article-title: MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop publication-title: J Clin Invest doi: 10.1172/JCI58849 – volume: 45 start-page: 973 year: 2013 ident: key20180107182109_b8-ijo-45-06-2421 article-title: LIN28/LIN28B: an emerging oncogenic driver in cancer stem cells publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2013.02.006 – volume: 183 start-page: 288 year: 2013 ident: key20180107182109_b10-ijo-45-06-2421 article-title: Lin28 promotes growth of prostate cancer cells and activates the androgen receptor publication-title: Am J Pathol doi: 10.1016/j.ajpath.2013.03.011 – volume: 52 start-page: 70 year: 2013 ident: key20180107182109_b21-ijo-45-06-2421 article-title: miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells publication-title: Mol Carcinog doi: 10.1002/mc.21832 – reference: 23821659 - Blood. 2013 Sep 12;122(11):1891-9 – reference: 22121083 - Mol Carcinog. 2013 Jan;52(1):70-8 – reference: 22314551 - Prostate. 2012 Sep 15;72(13):1453-63 – reference: 20947150 - Gynecol Oncol. 2011 Jan;120(1):145-51 – reference: 21637912 - Int J Mol Med. 2011 Sep;28(3):327-36 – reference: 21310526 - Cancer Lett. 2011 Apr 1;303(1):56-64 – reference: 20360767 - Nat Protoc. 2010 Apr;5(4):725-38 – reference: 24206221 - Expert Opin Drug Discov. 2013 Dec;8(12):1491-501 – reference: 22156201 - J Clin Invest. 2012 Jan;122(1):33-47 – reference: 23337528 - Endocrinology. 2013 Mar;154(3):1321-36 – reference: 23420006 - Int J Biochem Cell Biol. 2013 May;45(5):973-8 – reference: 22114071 - Carcinogenesis. 2012 Feb;33(2):338-47 – reference: 18644693 - Eur J Surg Oncol. 2009 Apr;35(4):339-47 – reference: 11846609 - Methods. 2001 Dec;25(4):402-8 – reference: 23145211 - Am J Transl Res. 2012;4(4):432-42 – reference: 22479342 - PLoS One. 2012;7(3):e32832 – reference: 22082758 - Semin Oncol. 2011 Dec;38(6):724-33 – reference: 19676045 - Int J Cancer. 2010 Mar 1;126(5):1166-76 – reference: 23063642 - FEBS Lett. 2012 Nov 16;586(22):3986-90 – reference: 21296855 - CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90 – reference: 22078496 - Cell. 2011 Nov 23;147(5):1080-91 – reference: 23609190 - Med Oncol. 2013;30(2):577 – reference: 23377967 - Adv Exp Med Biol. 2013;774:39-53 – reference: 23481595 - RNA. 2013 May;19(5):613-26 – reference: 23553990 - J Cell Biochem. 2013 Sep;114(9):2160-9 – reference: 24411213 - Urology. 2014 Mar;83(3):664-9 – reference: 23781281 - J Cancer. 2013 May 09;4(5):350-7 – reference: 23790802 - Am J Pathol. 2013 Jul;183(1):288-95 – reference: 20805998 - PLoS One. 2010;5(8):e12445 – reference: 20005451 - Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):5-8 – reference: 22110741 - PLoS One. 2011;6(11):e27722 – reference: 23111773 - Cell Tissue Res. 2013 Jan;351(1):85-98 – reference: 23169280 - Br J Cancer. 2012 Dec 4;107(12):1987-96 – reference: 23803080 - Asian Pac J Cancer Prev. 2013;14(5):3063-6 – reference: 23183268 - Endocr Relat Cancer. 2013 Feb;20(1):91-102 – reference: 21980038 - Cancer Genomics Proteomics. 2011 Sep-Oct;8(5):235-44 – reference: 23436656 - J Biol Chem. 2013 Apr 19;288(16):10973-85 – reference: 22161865 - Prostate. 2012 Aug 1;72(11):1171-8 |
| SSID | ssj0025501 |
| Score | 2.22043 |
| Snippet | Lin28 is a family of RNA binding proteins and microRNA regulators. Two members of this family have been identified: Lin28A and Lin28B, which are encoded by... |
| SourceID | pubmedcentral proquest gale pubmed crossref spandidos |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2421 |
| SubjectTerms | Analysis androgen-independent prostate cancer Androgens Androgens - metabolism Binding proteins c-Myc downregulation Cell cycle Cell Line, Tumor Cell Proliferation - genetics Development and progression Gene expression Gene Expression Regulation, Neoplastic Genetic aspects Humans Immunoglobulins Lin28B silencing Lin28B-miR-212-c-Myc pathway Male Metastasis MicroRNA microRNA regulation MicroRNAs MicroRNAs - genetics MicroRNAs - metabolism miR-212 Physiological aspects Prostate cancer Prostatic Neoplasms - genetics Prostatic Neoplasms - pathology Proteins Proto-Oncogene Proteins c-myc - biosynthesis Proto-Oncogene Proteins c-myc - genetics RNA, Messenger - biosynthesis RNA-Binding Proteins - antagonists & inhibitors RNA-Binding Proteins - biosynthesis RNA-Binding Proteins - genetics |
| Title | A potential regulatory loop between Lin28B:miR-212 in androgen-independent prostate cancer |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/25201220 https://www.proquest.com/docview/1932879198 https://www.proquest.com/docview/1616477350 https://pubmed.ncbi.nlm.nih.gov/PMC4215582 |
| Volume | 45 |
| WOSCitedRecordID | wos000344200700027&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1791-2423 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025501 issn: 1019-6439 databaseCode: 7X7 dateStart: 20120101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1791-2423 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025501 issn: 1019-6439 databaseCode: 7RV dateStart: 20120101 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1791-2423 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025501 issn: 1019-6439 databaseCode: BENPR dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RLaJceBcCpRgJwQXTvLx2uKAtasWlq9UK0IpLlNheEVSSkE2R-PfMJN7QVIILl0iRx8pj3vZ4PoAXKqa9MRVxtIo5j_PE8MxMQ77OVaIiIwgQvgObkPO5Wq2ShVtw27iyyq1N7Ay1qTStkR9RoKFkgjnyu_oHJ9Qo2l11EBo7sEudyuIJ7B6fzBfLIeXC-LtLuTCQ4eR7-y6b6KTDo-Ibnf0L4jcYEsiRV7pqmy85p6uFk3uo9qUpTLW55JVOb__v99yBWy4eZbNegO7CNVvegxtnbsf9PnyZsbpqqaQIqZoeuL5qfrHzqqqZK_JimNCG6vjt92LJ0UexomQZ9UFA2eTFALPbsppOmGBsyzSJWvMAPp2efHz_gTs8Bq4xzmq5sVbEWYYJivaVtH6gEq2mvgl9Kj2x69xodIjSKhnpdWKCDHMlGZvAaJELrWy0D5OyKu0jYEk-VWqNftEi16zOc4wcCP4syTLh4wwPXm_5kWrXrJwwM85TTFqIfSmyLyX2pcQ-D14O5HXfpeNvhM-IuWl_yHTQ7nRGaabyhQo8eNVRkH7jE3Xmjinge1OnrBHlwYgS9VKPh7eMT51d2KR_uO7B82GYZlKtW2mrC6SZUo83GQnfg4e9vA0fFYqQ9kJxRI4kcSCgbuHjkbL42nUNjzG4Eyr0gA0yO8zCf8RjQRVwVCHw-N9v_gRu0v_sa3oOYNI2F_YpXNc_22LTHMKOXH6m60p2V3XodBLv5ouz342fPJk |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9UwEB6VgigX9iVQqJFYLpgmecmzg4TQY6latX1CVYuqXtzE9oOgkoS8FNQ_xW9kJhtNJbj1wNnjLM4s38SfZwCeyID2xuSIo1dMeJBEhsdm7PNZIiM5MiE1hK-bTYjpVO7vRx8X4Fd3FoZolZ1PrB21yTX9I18loCFFhDnym-I7p65RtLvatdBo1GLTnvzElG3-euM9ft-nvr_2YffdOm-7CnCNaKHixtowiGOE2dqVwrqejLQcu8Z3iUBhZ4nR6NaFlWKkZ5HxYkT8IjCe0WESamlHeN0LcBH9uEcUMrHzqU_wEO3XCR7CJk6RvqnpiZDAX02_0klDL3iJAEQMYuDZSHAqFJ6laS6hk8lMavL5qRi4du1_W73rcLVF22zSmMcNWLDZTbi83fIJbsHBhBV5RYQplCrtZ-pllpcn7CjPC9ZS2Bim6758--pbusMxArM0YzFVeUDL42nfRLhiBZ2fQeTONBlSeRv2zuXN7sBilmf2HrAoGUs5w6hvvSiwOkkQF1FztyiOQxdnOPCi-_5Kt6XYqSPIkcKUjNRFobooUhdF6uLAs168aGqQ_E1whZRJNUdoe9-lJpRESzeUngPPawnyXnhHHbeHMPC5qQ7YQHJ5IIleRw-HO0VTrdebqz9a5sDjfphmEpMvs_kxyoypgp0Yha4Ddxv97l_KD33a6cURMdD8XoBqoQ9HsvRLXRM9QOgaSt8B1ttIPwvXiAch8fuI_3D_30--Akvru9tbamtjuvkArtDaNuylZVisymP7EC7pH1U6Lx_Vts_g8LzN5TcUTZcY |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VFBUuvAuGQheJx4Vt_NrsGgmhlDaiKkRRVaSKi7F312BU7OCkoP41fh0zsWPqSnDrgfPOJvZmHt9kv5kBeKJCuhtTAUevmPIwjQxPzMDnWaoiFRhBA-EXwybkeKyOjqLJCvxa1sIQrXLpExeO2pSa_iPvE9BQMsIcuZ81tIjJzuj19DunCVJ007ocp1GryL49_Ynp2-zV3g7-1k99f7R7-OYtbyYMcI3IYc6NtSJMEoTc2lXSup6KtBq4xneJTGGz1Gh08dIqGegsMl6C6F-GxjNapEIrG-DnXoJViSBD9GB1e3c8OWjTPcT-i3QPQRSnuF93-ESA4Pfzr1R36IVbCEdkJyKejwtnAuN50uYVdDmFyU05OxMRR9f_57O8AdcaHM6GteHchBVb3IK19w3T4DZ8HLJpOScqFUpV9jNNOSurU3ZcllPWkNsYJvK-2n75LT_gGJtZXrCE-j-gTfK8HS88Z1OqrEFMzzSZWHUHPlzIm61DrygLew9YlA6UyhAPWC8KrU5TREw09i1KEuHiDgdeLHUh1k2TdpoVchxjskaqE6PqxKQ6MamOA89a8WndneRvgpukWHFdXNt6tXhI6bVyhfIceL6QIL-G36iTpjwDn5s6hHUkNzqS6I90d3mpdHHjD2fxH41z4HG7TDuJ41fY8gRlBtTbTgbCdeBurevtS_nCpztgXJEdK2gFqEt6d6XIvyy6pYcIaoXyHWCtvbS78Ix4KIj5R8yI-_9-8k1YQyuJ3-2N9x_AVTramta0Ab15dWIfwmX9Y57PqkeNI2Dw6aLt5Tdo9qEM |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+potential+regulatory+loop+between+Lin28B%3AmiR-212+in+androgen-independent+prostate+cancer&rft.jtitle=International+journal+of+oncology&rft.au=Borrego-Diaz%2C+Emma&rft.au=Powers%2C+Benjamin+C&rft.au=Azizov%2C+Vugar&rft.au=Lovell%2C+Scott&rft.date=2014-12-01&rft.pub=Spandidos+Publications&rft.issn=1019-6439&rft.volume=45&rft.issue=6&rft.spage=2421&rft_id=info:doi/10.3892%2Fijo.2014.2647&rft.externalDocID=A401380581 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1019-6439&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1019-6439&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1019-6439&client=summon |